Alcentra Capital Corp (NASDAQ:ABDC) saw a significant drop in short interest in the month of October. As of October 31st, there was short interest totalling 4,700 shares, a drop of 17.5% from the September 30th total of 5,700 shares. Based on an average daily volume of 57,700 shares, the short-interest ratio is presently 0.1 days. Approximately 0.0% of the company’s shares are sold short.
Several equities research analysts have weighed in on the stock. ValuEngine upgraded shares of Alcentra Capital from a “sell” rating to a “hold” rating in a report on Friday, November 8th. Zacks Investment Research lowered shares of Alcentra Capital from a “hold” rating to a “sell” rating in a report on Friday, November 8th.
ABDC traded down $0.01 during mid-day trading on Wednesday, hitting $9.01. The stock had a trading volume of 1,560 shares, compared to its average volume of 41,497. The stock’s fifty day simple moving average is $8.88 and its 200-day simple moving average is $8.60. The firm has a market capitalization of $115.11 million, a price-to-earnings ratio of 8.92 and a beta of 0.55. Alcentra Capital has a 1-year low of $6.15 and a 1-year high of $9.40.
A number of institutional investors and hedge funds have recently bought and sold shares of ABDC. Morgan Stanley raised its holdings in shares of Alcentra Capital by 120.8% during the second quarter. Morgan Stanley now owns 438,715 shares of the asset manager’s stock worth $3,676,000 after acquiring an additional 240,027 shares during the period. Acadian Asset Management LLC raised its holdings in shares of Alcentra Capital by 40.8% during the second quarter. Acadian Asset Management LLC now owns 17,196 shares of the asset manager’s stock worth $145,000 after acquiring an additional 4,985 shares during the period. Pacific Ridge Capital Partners LLC raised its holdings in shares of Alcentra Capital by 2.4% during the second quarter. Pacific Ridge Capital Partners LLC now owns 456,870 shares of the asset manager’s stock worth $3,829,000 after acquiring an additional 10,918 shares during the period. Finally, Appleton Partners Inc. MA acquired a new stake in shares of Alcentra Capital during the second quarter worth $89,000. Institutional investors own 38.10% of the company’s stock.
About Alcentra Capital
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
Featured Article: What are some reasons analysts would give stocks a buy rating?
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.